Who to screen for MRSA
Outlines a more focused, cost-effective approach to MRSA screening whilst concentrating on reducing infections and improving patient health.
The guidance, from the Expert Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI), recommends a more efficient and effective method for identifying and managing high-risk patients who have tested positive for MRSA. However, NHS Trusts need to take into account local risks as well as the recommendations so they can get the best results in their hospitals.
This guidance draws on the outputs of the National One Week (NOW) study and could be used to inform policy making decisions should the prevalence of MRSA increase.
Published 18 August 2014